1. EZH2 Inhibition and Cisplatin as a Combination Anticancer Therapy: An Overview of Preclinical Studies
   Ivana Samaržija et al, 2022, Cancers CrossRef
2. Clinicopathologic significance of protein lysine methyltransferases in cancer
   Theodore Vougiouklakis et al, 2020, Clinical Epigenetics CrossRef
3. Depletion of enhancer zeste homolog 2 (EZH2) directs transcription factors associated with T cell differentiation through epigenetic regulation of Yin Yang 1(YY1) in combating non-small cell lung cancer (NSCLC)
   Nikhil Chandnani et al, 2023, Medical Oncology CrossRef
4. Epigenetic silencing of downstream genes mediated by tandem orientation in lung cancer
   Steffen Kiehl et al, 2017, Scientific Reports CrossRef